Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
05 Mar 2021
Historique:
pubmed: 27 9 2020
medline: 3 11 2021
entrez: 26 9 2020
Statut: ppublish

Résumé

Paediatric data on the association between diagnostic delay and inflammatory bowel disease [IBD] complications are lacking. We aimed to determine the effect of diagnostic delay on stricturing/fistulising complications, surgery, and growth impairment in a large paediatric cohort, and to identify predictors of diagnostic delay. We conducted a national, prospective, multicentre IBD inception cohort study including 1399 children. Diagnostic delay was defined as time from symptom onset to diagnosis >75th percentile. Multivariable proportional hazards [PH] regression was used to examine the association between diagnostic delay and stricturing/fistulising complications and surgery, and multivariable linear regression to examine the association between diagnostic delay and growth. Predictors of diagnostic delay were identified using Cox PH regression. Overall (64% Crohn's disease [CD]; 36% ulcerative colitis/IBD unclassified [UC/IBD-U]; 57% male]), median time to diagnosis was 4.2 (interquartile range [IQR] 2.0-9.2) months. For the overall cohort, diagnostic delay was >9.2 months; in CD, >10.8 months and in UC/IBD-U, >6.6 months. In CD, diagnostic delay was associated with a 2.5-fold higher rate of strictures/internal fistulae (hazard ratio [HR] 2.53, 95% confidence interval [CI] 1.41-4.56). Every additional month of diagnostic delay was associated with a decrease in height-for-age z-score of 0.013 standard deviations [95% CI 0.005-0.021]. Associations persisted after adjusting for disease location and therapy. No independent association was observed between diagnostic delay and surgery in CD or UC/IBD-U. Diagnostic delay was more common in CD, particularly small bowel CD. Abdominal pain, including isolated abdominal pain in CD, was associated with diagnostic delay. Diagnostic delay represents a risk factor for stricturing/internal fistulising complications and growth impairment in paediatric CD. This article has an associated podcast which can be accessed at https://academic.oup.com/ecco-jcc/pages/podcast.

Sections du résumé

BACKGROUND BACKGROUND
Paediatric data on the association between diagnostic delay and inflammatory bowel disease [IBD] complications are lacking. We aimed to determine the effect of diagnostic delay on stricturing/fistulising complications, surgery, and growth impairment in a large paediatric cohort, and to identify predictors of diagnostic delay.
METHODS METHODS
We conducted a national, prospective, multicentre IBD inception cohort study including 1399 children. Diagnostic delay was defined as time from symptom onset to diagnosis >75th percentile. Multivariable proportional hazards [PH] regression was used to examine the association between diagnostic delay and stricturing/fistulising complications and surgery, and multivariable linear regression to examine the association between diagnostic delay and growth. Predictors of diagnostic delay were identified using Cox PH regression.
RESULTS RESULTS
Overall (64% Crohn's disease [CD]; 36% ulcerative colitis/IBD unclassified [UC/IBD-U]; 57% male]), median time to diagnosis was 4.2 (interquartile range [IQR] 2.0-9.2) months. For the overall cohort, diagnostic delay was >9.2 months; in CD, >10.8 months and in UC/IBD-U, >6.6 months. In CD, diagnostic delay was associated with a 2.5-fold higher rate of strictures/internal fistulae (hazard ratio [HR] 2.53, 95% confidence interval [CI] 1.41-4.56). Every additional month of diagnostic delay was associated with a decrease in height-for-age z-score of 0.013 standard deviations [95% CI 0.005-0.021]. Associations persisted after adjusting for disease location and therapy. No independent association was observed between diagnostic delay and surgery in CD or UC/IBD-U. Diagnostic delay was more common in CD, particularly small bowel CD. Abdominal pain, including isolated abdominal pain in CD, was associated with diagnostic delay.
CONCLUSIONS CONCLUSIONS
Diagnostic delay represents a risk factor for stricturing/internal fistulising complications and growth impairment in paediatric CD.
PODCAST UNASSIGNED
This article has an associated podcast which can be accessed at https://academic.oup.com/ecco-jcc/pages/podcast.

Identifiants

pubmed: 32978629
pii: 5911915
doi: 10.1093/ecco-jcc/jjaa197
pmc: PMC7944510
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

419-431

Subventions

Organisme : NIDDK NIH HHS
ID : RC2 DK118640
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Amanda Ricciuto (A)

SickKids Hospital, University of Toronto, Toronto, ON, Canada.

David R Mack (DR)

Children's Hospital of Eastern Ontario [CHEO], Inflammatory Bowel Disease Centre, Ottawa, ON, Canada.

Hien Q Huynh (HQ)

Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.

Kevan Jacobson (K)

B.C. Children's Hospital, Vancouver, BC, Canada.

Anthony R Otley (AR)

IWK Health Centre, Halifax, NS, Canada.

Jennifer deBruyn (J)

Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.

Wael El-Matary (W)

Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.

Colette Deslandres (C)

CHU Sainte-Justine, Montreal, QC, Canada.

Mary E Sherlock (ME)

McMaster Children's Hospital, Hamilton, ON, Canada.

Jeffrey N Critch (JN)

Janeway Children's Health and Rehabilitation Centre, St. John's, NL, Canada.

Kevin Bax (K)

Children's Hospital of Western Ontario, London, ON, Canada.

Prevost Jantchou (P)

CHU Sainte-Justine, Montreal, QC, Canada.

Ernest G Seidman (EG)

Montreal Children's Hospital, Montreal, QC, Canada.

Nicholas Carman (N)

Children's Hospital of Eastern Ontario [CHEO], Inflammatory Bowel Disease Centre, Ottawa, ON, Canada.

Mohsin Rashid (M)

IWK Health Centre, Halifax, NS, Canada.

Aleixo Muise (A)

SickKids Hospital, University of Toronto, Toronto, ON, Canada.

Eytan Wine (E)

Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.

Matthew W Carroll (MW)

Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.

Sally Lawrence (S)

B.C. Children's Hospital, Vancouver, BC, Canada.

Johan Van Limbergen (J)

IWK Health Centre, Halifax, NS, Canada.

Eric I Benchimol (EI)

Children's Hospital of Eastern Ontario [CHEO], Inflammatory Bowel Disease Centre, Ottawa, ON, Canada.
CHEO Research Institute, Ottawa, ON, Canada.
Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
ICES uOttawa, Ottawa, ON, Canada.

Thomas D Walters (TD)

SickKids Hospital, University of Toronto, Toronto, ON, Canada.

Anne M Griffiths (AM)

SickKids Hospital, University of Toronto, Toronto, ON, Canada.

Peter C Church (PC)

SickKids Hospital, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH